Physician profile
Cheryl Glover
NPI 1275031445
$427.69
in general payments reported to CMS, 2019-2025
9 companies · $61.76 in 2025
The $61.76 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $29.71 · 2023: $98.96 · 2024: $86.28 · 2025: $61.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $122.59 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Corium, LLC | $90.33 | 2021-2025 | Azstarys |
| Pfizer INC. | $45.44 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.76 | 2021 | |
| Sanofi Pasteur INC. | $40.85 | 2021-2023 | |
| Alk-Abello, INC | $34.06 | 2023-2024 | Grastek, Odactra, Ragwitek |
| Sobi, INC | $20.48 | 2023 | |
| Glaxosmithkline, LLC. | $16.10 | 2021 | |
| Cranial Technologies, INC | $15.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Glover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.